FIB-4 False Negatives in MASLD: Clinical Phenotypes and an Augmented Triage Model
APASL Single Topic Conference (STC) 2026, Kumamoto, Japan. Oral presentation FP5-2, 2026
Among MASLD patients classified as low-risk by FIB-4 (NHANES 2017–2020), 16.6% had significant (F2+) fibrosis, rising to 37.7% at BMI ≥ 40 kg/m². A supplementary model, FIB-4 Plus, outperformed the NAFLD Fibrosis Score (AUROC 0.837 vs. 0.749, DeLong p = 0.019). Oral presentation; APASL International Travel Award.
Recommended citation: M. A. Khan. (2026). "FIB-4 False Negatives in MASLD: Clinical Phenotypes and an Augmented Triage Model." Oral presentation FP5-2 (Abstract No. 10340), APASL Single Topic Conference 2026, Kumamoto, Japan.
Download Slides
